Prospect News: News for Acorda Therapeutics, Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with A > Issuers starting with A, PP only > All stories on Acorda Therapeutics, Inc. > Stories on Acorda Therapeutics, Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Acorda Therapeutics, Inc.

1/25/2016	PP	Acorda Therapeutics lines up $75 million private placement of shares
1/19/2016	PP	Acorda plans $75 million private placement of stock, $60 million loan
9/11/2014	PP	Market Commentary: Twitter’s $1.3 billion offering around issue in gray market; WellPoint drops; Tesla slips
6/20/2014	PP	Market Commentary: Intel’s convertible debt rises in active trading; new Acorda 1.75% notes inching higher
6/18/2014	PP	Market Commentary: Acorda, EZCorp end flat after early weakness; planned Restoration Hardware bid above issue
6/17/2014	PP	Market Commentary: Three deals on tap; Acorda looks slightly cheap; Restoration Hardware looks slightly rich
6/16/2014	PP	Market Commentary: Convertibles quiet; Intel, Tesla in line; Acorda, Restoration Hardware, EZCorp to price
10/6/2006	PP	Market Commentary: Memory Pharma PIPE to help complete trials; Access Integrated raises $22 million from notes
10/5/2006	PP	Market Commentary: Acorda PIPE boosted cash following disappointing IPO, chief says; Memory secures $31.3 million
10/5/2006	BTPP	New Issue: Acorda Therapeutics gives details of $31.5 million stock sale
10/4/2006	PP	Market Commentary: Acorda secures $31.5 million from stock offering; Dynavax plans $27.28 million direct stock sale
10/4/2006	BTPP	New Issue: Acorda secures $31.5 million from private placement of stock

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.